A randomized controlled study on the effects of gargling with tea catechin extracts on the prevention of influenza infection in healthy adults

Japanese Journal of Clinical Pharmacology and Therapeutics

Volumn 38, Issue 5, 2007, Pages 323-329

  Yamada, Hiroshi ^a   Daimon, Takashi ^a   Matsuda, Katsuhiko ^b   Yoshida, Masayuki ^c   Takuma, Norikata ^d   Hara, Yukihiko ^e  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b SHIZUOKA GENERAL HOSPITAL   (Japan)

^c SEIREI HAMAMATSU GENERAL HOSPITAL   (Japan)

^d White Cross Nursing Home   (Japan)

^e Mitsui Norin Co Ltd ^*  (Japan)

Author keywords

Catechin; Gargling; Healthy adults; Influenza infection; Prophylaxis

Indexed keywords

CATECHIN; CATECHIN GALLATE; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALLOCATECHIN; GALLOCATECHIN GALLATE; PLACEBO; POLYPHENON 70A; UNCLASSIFIED DRUG;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRONCHOPNEUMONIA; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; DRUG WITHDRAWAL; HUMAN; INCIDENCE; INFECTION RATE; INFLUENZA; MOUTH HYGIENE; NORMAL HUMAN; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TEA; THROAT IRRITATION; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 35748937079     PISSN: 03881601     EISSN: None     Source Type: Journal    
DOI: 10.3999/jscpt.38.323     Document Type: Article

References (30)

1. Jefferson T. Influenza vaccination: policy versus evidence. BMJ 2006; 333: 912-5.
2. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179-86.
3. van der Wouden JC, Bueving HJ, Poole P. Preventing influenza: an overview of systematic reviews. Respir Med 2005; 99: 1341-9.
4. Jefferson T, Demicheli V, Rivetti D, Jones M, Di Pietrantonj C, Rivetti A. Antivirals for influenza in healthy adults: systematic review. Lancet 2006; 367: 303-13.
5. Gwaltney JM. Clinical significance and pathogenesis of viral respiratory infections. Am J Med 2002; 112: 13S-8S.
6. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 2003; 163: 487-94.
7. Cooper R, Morre DJ, Morre DM. Medicinal benefits of green tea: part I. Review of noncancer health benefits. J Altern Complement Med 2005; 11: 521-8.
8. Mukhtar H, Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 2000; 71: 1698S-702S.
9. Nakayama M, Suzuki K, Toda M, Okubo S, Hara Y, Shimamura T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res 1993; 21: 289-99.
10. Nakayama M, Toda M, Okubo S, Hara Y, Shimamura T. Inhibition of the infectivity of influenza virus by black tea extract. Kansenshogaku Zasshi 1994; 68: 824-9 (in Japanese).
11. Sidwell RW, Huffman JH, Moscon BJ, Warren RP. Influenza virus-inhibitory effects of intraperitoneally and aerosol-administered SP-303, a plant flavonoid. Chemotherapy 1994; 40: 42-50.
12. Mantani N, Imanishi N, Kawamata H, Terasawa K, Ochiai H. Inhibitory effect of (+)-catechin on the growth of influenza A/PR/8 virus in MDCK cells. Planta Med 2001: 67: 240-3.
13. Imanishi N, Tuji Y, Katada Y, Maruhashi M, Konosu S, Mantani N, Terasawa K, Ochiai H. Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells. Microbiol Immunol 2002; 46: 491-4.
14. Song JM, Lee KH, Seong BL. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res 2005; 68: 66-74.
15. Wyde PR, Ambrose MW, Meyerson LR, Gilbert BE. The antiviral activity of SP-303, a natural polyphenolic polymer, against respiratory syncytial and parainfluenza type 3 viruses in cotton rats. Antiviral Res 1993; 20: 145-54.
16. Weber JM, Ruzindana-Umunyana A, Imbeault L, Sircar S. Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Res 2003; 58: 167-73.
17. Iwata M, Toda M, Nakayama M, Tsujiyama H, Endo W, Takahashi O, Hara Y, Shimamura T. Prophylactic effect of black tea extract as gargle against influenza. Kansenshogaku Zasshi 1997; 71: 487-94 (in Japanese).
18. Iwata M, Toda M, Nakayama M, Hara Y, Shimamura T. Comparison between black tea and gargles on inhibition of the infectivity of influenza virus. Kansenshogaku Zasshi 1997; 71: 1175-7 (in Japanese).
19. Yamada H, Takuma N, Daimon T, Kara Y. Gargling with tea catechin extracts for the prevention of influenza infection in elderly nursing home residents: a prospective clinical study. J Altern Complement Med 2006; 12: 669-72.
20. Jackson GG, Dowling HF, Spiesman IG, Boand AV. Transmission of the common cold to volunteers under controlled conditions: I. The common cold as a clinical entity. Arch Intern Med 1958; 101: 267-78.
21. World Health Organization (WHO) website: http://www. who.int/mediacentre/ factsheets/fs211/en/
22. Centers for Disease Control and Prevention (CDC). Update: influenza activity-United States and worldwide, 2005-06 season, and composition of the 2006-07 influenza vaccine. Morb Mortal Wkly Rep 2006; 55: 648-53.
23. Surveillance Data Table (Sentinel-Reporting Diseases). Infectious Disease Surveillance Center (IDSC), National Institute of Infectious Diseases, website: http://idsc.nih.go. jp/idwr/ydata/report-Eb.html.
24. Poehling KA, Edwards KM, Weinberg GA, et al. The under-recognized burden of influenza in young children. N Engl J Med 2006; 355: 31-40.
25. Ellis SE, Coffey CS, Mitchel EF Jr, Dittus RS, Griffin MR. Influenza-and respiratory syncytial virus-associated morbidity and mortality in the nursing home population. J Am Geriatr Soc 2003: 51: 761-7.
26. Yamada H. Protective effects of tea against lung/pulmonary ailments. Jain NK, Siddiqi MA, Weisburger JH (Eds). Protective Effects of Tea on Human Health. Oxford: CABI publishing, 2006: 149-57.
27. Satomura K, Kitamura T, Kawamura T, Shimbo T, Watanabe M, Kamei M, Takano Y, Tamakoshi A; Great Cold Investigators-I. Prevention of upper respiratory tract infections by gargling : a randomized trial. Am J Prev Med 2005; 29: 302-7.
28. Shirai T, Sato A, Kara Y. Epigallocatechin gallate: the major causative agent of green tea-induced asthma. Chest 1994; 106: 1801-5.
29. Shirai T, Reshad K, Yoshitomi A, Chida K, Nakamura H, Taniguchi M. Green tea-induced asthma: relationship between immunological reactivity, specific and non-specific bronchial responsiveness. Clin Exp Allergy 2003; 33: 1252-5.
30. Yamane T, Nakatani H, Kikuoka N, Matsumoto H, Iwata Y, Kitao Y, Oya K, Takahashi T. Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis. Cancer 1996; 77: 1662-7.